Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Acute Coronary Syndrome

Next Previous
X
Search
Trial Profile

Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Acute Coronary Syndrome

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Feb 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clopidogrel (Primary) ; Ticagrelor (Primary) ; Aspirin
  • Indications Acute coronary syndromes; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms CCC-ACS

    • Most Recent Events

    • 02 Feb 2023 Results evaluating association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome , published in the European Journal of Medical Research
    • 08 Nov 2022 Results (n=40670) assessing risk factors of STEMI patients with in-hospital cardiac arrest published in the Journal of the American College of Cardiology
    • 01 Nov 2022 Results(n=18,244 ) comparing the in-hospital outcomes of ticagrelor versus clopidogrel in older patients with acute coronary syndrome published in the Age and Ageing

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top